← FDA Drug Approvals (Drugs@FDA)
PLENVU
NDA · New Drug Application · Sponsor: SALIX · Approved 2018-05-04
Drug application
- FDA Application #
NDA209381- Application type
- New Drug Application
- Brand name
- PLENVU
- Generic name
- POLYETHYLENE GLYCOL 3350, SODIUM SULFATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE, ASCORBIC ACID, SODIUM ASCORBATE
- Active ingredients
- ASCORBIC ACID; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM ASCORBATE; SODIUM CHLORIDE; SODIUM SULFATE
- Dosage form
- FOR SOLUTION
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- SALIX
- Manufacturer
- Salix Pharmaceuticals, Inc
- First approval
- 2018-05-04
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown